Search Ontology:
ChEBI
alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp
- Term ID
- CHEBI:61357
- Synonyms
-
- (Gal)2 (Glc)1 (GlcNAc)1 (LFuc)1
- 6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
- alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc
- alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
- alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose
- Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc
- H type I
- Lacto-N-fucopentaitol I
- Lacto-N-fucopentaose I
- LNF-I
- LNFP I
- LNFPI
- Definition
- A linear amino pentasaccharide comprising one fucose, two galactose, one glucosamine and one glucose unit (at the reducing end), linked as shown.
- References
-
- glygen:G01650PH
- glytoucan:G01650PH
- kegg.glycan:G00535
- pubmed:11425797
- pubmed:15158661
- pubmed:15262925
- pubmed:1695678
- pubmed:2413844
- pubmed:27558427
- pubmed:2776132
- pubmed:3274083
- pubmed:3397933
- pubmed:8675304
- pubmed:9271064
- reaxys:6050700
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp
Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp
Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp
Phenotype affecting alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp
Human Disease Model